© franckreporter / Getty Images

Takeda signs 12-year renewable energy agreement in US

By Ben Hargreaves

Adding to broader action being taken across the industry, the company has signed an agreement with Enel for the supply of renewable energy credits covering its electricity needs across the US.

(Image: Getty/Gordan1)

Takeda backs microbiome biotech

By Staff Reporter

Enterome completes Series E financing round, with Takeda returning to provide funds to the biotech.

(Image: Getty/Tampatra)

Year begins with bang for AI drug development

By Ben Hargreaves

Alongside the first drug developed by AI entering clinical trials, there have been a number of other instances of the technology being used to aid the discovery of new treatments.

(Image: Getty/BobHemphill)

Takeda sheds products in emerging markets in $200m deal

By Ben Hargreaves

Takeda has sold selected prescription and OTC products to Acino covering its Near East, Middle East and Africa portfolio, as it looks to trim down its portfolio following the acquisition of Shire.

(Image: Getty/dk_photos)

PRA buys out Takeda JV in Japan

By Melissa Fassbender

PRA Health Sciences has bought out its joint venture with Takeda, establishing a new subsidiary based in Japan – a rapidly growing market, says EVP.

(Image: Getty/SeanPastonePhoto)

Takeda to move US base to Boston

By Ben Hargreaves

Takeda will become the latest company to base its operations within Massachusetts, after announcing it would leave its Deerfield, Illinois headquarters.


Follow us


View more


Featured Suppliers